Serine/threonine-protein kinase mTOR (89-98)

Serine/threonine-protein kinase mTOR

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-057

Synonyms/Alias:Serine/threonine-protein kinase mTOR (89-98)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
AIASLIGVEG
Areas of Interest
Antigen-presenting Cells; Cancer Research

Serine/threonine-protein kinase mTOR (89-98) is a synthetic peptide fragment derived from the mechanistic target of rapamycin (mTOR), a central regulator of cell growth, proliferation, and metabolism in eukaryotic systems. This decapeptide corresponds to amino acid residues 89 through 98 within the mTOR protein sequence, a region that may contribute to substrate recognition, protein-protein interactions, or post-translational modification events. As a research tool, this peptide enables targeted investigation of mTOR's structural domains, signaling pathways, and regulatory mechanisms, supporting advanced studies in cellular signaling, cancer biology, and metabolic regulation. Its defined sequence and biochemical properties make it a valuable asset for laboratories engaged in dissecting the molecular underpinnings of mTOR-mediated processes.

Peptide mapping and epitope characterization: Researchers frequently utilize the 89-98 fragment of mTOR in peptide mapping experiments to identify antibody binding sites or characterize linear epitopes within the mTOR protein. By serving as a defined antigenic determinant, this peptide allows for the precise validation of antibody specificity in immunoassays such as ELISA, western blotting, or immunoprecipitation. Such studies are essential for the development of reliable immunodetection reagents and for dissecting the molecular interactions between mTOR and regulatory proteins or therapeutic antibodies.

Kinase substrate studies: The 89-98 peptide can function as a model substrate in in vitro kinase assays designed to probe the enzymatic activity of mTOR and related serine/threonine kinases. By providing a defined phosphorylation target, it facilitates the assessment of kinase-substrate specificity, catalytic efficiency, and the impact of regulatory cofactors or inhibitors. These experiments are critical for elucidating the substrate recognition motifs of mTOR and for screening small molecules that modulate its kinase activity in a controlled biochemical context.

Protein-protein interaction analysis: The defined sequence of this peptide fragment enables its use in binding studies to investigate interactions between mTOR and other signaling proteins, adaptor molecules, or regulatory domains. Techniques such as surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), or peptide pull-down assays can leverage this fragment to map interaction interfaces and quantify binding affinities. Such applications contribute to a deeper understanding of how mTOR integrates upstream signals and orchestrates downstream cellular responses.

Phosphorylation site identification: Employing the 89-98 peptide as a standard or analytical probe in mass spectrometry-based workflows allows for the detection and quantification of phosphorylation events within this region of mTOR. By serving as a reference or calibration standard, it supports the identification of post-translational modifications in complex biological samples, aiding in the elucidation of mTOR's regulatory phosphorylation sites and their functional significance in signaling cascades.

Structural and conformational studies: The synthetic peptide corresponding to residues 89-98 of mTOR can be used in structural biology approaches, such as nuclear magnetic resonance (NMR) spectroscopy or circular dichroism (CD) analysis, to investigate local secondary structure propensities and conformational dynamics. Insights gained from these studies inform the understanding of mTOR's domain architecture and may reveal how sequence-specific features contribute to its biological activity and interaction landscape.

Source#
Homo sapiens (human)
Epitope
89-98
Restricting HLA
HLA-A2
References
Ramila Philip; J Proteome Res 2007

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide CDMOPeptide Analysis ServicesPeptide Modification ServicesCustom Conjugation ServiceEpitope Mapping ServicesPeptide Synthesis ServicescGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers